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https://doi.org/10.1016/j.celrep.2020.01.046SUMMARY
Obesity leads to a state of chronic, low-grade inflam-
mation that features the accumulation of lipid-laden
macrophages in adipose tissue. Here, we deter-
mined the role of macrophage lipid-droplet accumu-
lation in the development of obesity-induced
adipose-tissue inflammation, using mice with
myeloid-specific deficiency of the lipid-inducible
HILPDA protein. HILPDA deficiency markedly
reduced intracellular lipid levels and accumulation
of fluorescently labeled fatty acids. Decreased lipid
storage in HILPDA-deficient macrophages can be
rescued by inhibition of adipose triglyceride lipase
(ATGL) and is associated with increased oxidative
metabolism. In diet-induced obese mice, HILPDA
deficiency does not alter inflammatory andmetabolic
parameters, despite markedly reducing lipid
accumulation in macrophages. Overall, we find that
HILPDA is a lipid-inducible, physiological inhibitor
of ATGL-mediated lipolysis in macrophages and un-
couples lipid storage in adipose tissue macrophages
from inflammation and metabolic dysregulation. Our
data question the contribution of lipid droplet accu-
mulation in adipose tissue macrophages in obesity-
induced inflammation and metabolic dysregulation.
INTRODUCTION
The prevalence of obesity across theworld has risen steeply in the
past decades and has become a huge public health concern. It isCell Rep
This is an open access article under the CC BY-Nwell established that obesity is associated with a state of chronic,
low-grade inflammation. That low-grade inflammation is charac-
terized by increased production of several inflammatory cytokines
and adipokines and has been suggested to be an important
pathophysiological mechanism underlying many of the adverse
health effects of obesity (Gregor and Hotamisligil, 2011). In partic-
ular, the increase in inflammatory cytokines and adipokines is
believed to disrupt insulin signaling and to contribute to obesity-
induced insulin resistance (Hotamisligil, 2017).
Adipose tissuemainly consists of adipocytes, but it also harbors
numerous immune cells, including macrophages. Those macro-
phages are important for maintaining homeostasis in healthy
adipose tissue but also contribute to the development of inflam-
mation during obesity (Boutens and Stienstra, 2016). In lean
states, adipose tissue macrophages mainly show anti-inflamma-
tory phenotypes and are distributed evenly throughout the adi-
pose tissue. In contrast, in obese adipose tissue, macrophages
accumulate in so-called crown-like structures arounddeadadipo-
cytes and display ametabolically activated phenotype (Cinti et al.,
2005; Lumeng et al., 2007; Xu et al., 2013).Metabolically activated
macrophages formmultiple intracellular lipid droplets and display
distinct transcriptional profiles (Lumeng et al., 2008; Shapiro et al.,
2013; Xu et al., 2013). Those features reflect an attempt by mac-
rophages to buffer excess lipids, which is adaptive in the lean
state but becomes maladaptive in obese adipose tissue (Boutens
and Stienstra, 2016). The lipid-laden macrophages observed in
obese adipose tissue are reminiscent of the foamy macrophages
present in atherosclerotic plaques. Although foam cell formation
and adipose tissue inflammation are known to co-exist in obesity,
the exact role of lipid droplet accumulation in adipose tissue
macrophages in the development of obesity-induced adipose
tissue inflammation and associated metabolic disturbances re-
mains unclear.orts 30, 1811–1822, February 11, 2020 ª 2020 The Author(s). 1811
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
HILPDA (hypoxia inducible lipid droplet associated) is a small,
lipid-droplet-associated protein expressed in several tissues
(Mattijssen et al., 2014). The expression of Hilpda is induced
by different stimuli, including hypoxia, beta-adrenergic activa-
tion, and PPAR transcription factors (Gimm et al., 2010; Mattijs-
sen et al., 2014; Dijk et al., 2017). Gain- and loss-of-function
studies have shown that HILPDApromotes lipid deposition in he-
patocytes, adipocytes, and macrophages (Gimm et al., 2010;
Mattijssen et al., 2014; DiStefano et al., 2015, 2016; Dijk et al.,
2017; Maier et al., 2017). The mechanism by which HILPDA pro-
motes lipid storage in cells has not been completely elucidated,
but evidence has been presented that HILPDA directly binds and
inhibits adipose triglyceride lipase (ATGL) (Zhang et al., 2017;
Padmanabha Das et al., 2018), consistent with the ability of
HILPDA to inhibit lipolysis (DiStefano et al., 2015; Dijk et al.,
2017). Interestingly, endothelial cell marker Tie2-Cre-driven
deletion of Hilpda was found to decrease fatty acid and oxidized
low-density lipoprotein (oxLDL)-driven lipid droplet formation in
macrophages and reduce lesion formation and progression of
atherosclerosis in Apoe/ mice (Maier et al., 2017).
Here, we aimed to determine the exact role of HILPDA in lipid
storage in macrophages and to explore the potential causal rela-
tionship between lipid droplet accumulation in adipose tissue
macrophages and the development of adipose tissue inflamma-
tion and insulin resistance during obesity.
RESULTS
Hilpda as Gene of Interest in Obese Adipose Tissue
To identify genes that may be able to modify lipid storage in
adipose tissue macrophages, we searched for genes that are
induced by lipids and upregulated in adipose tissue
macrophages by obesity. To that end, we co-analyzed the
transcriptomics data from three experiments: (1) adipose tissue
macrophages isolated from obese versus lean mice, (2) mouse
peritoneal macrophages treated with the fatty acid oleate, and
(3) mouse peritoneal macrophages treated with intralipid, a
triglyceride emulsion. Scatterplot analysis identified Hilpda as a
gene of particular interest (Figure 1A) because it was the only
gene that was strongly upregulated in all three experiments.
Moreover,Hilpdawas themost highly induced gene in peritoneal
macrophages by oleate. Consistent with a potential role for
Hilpda in obese-induced adipose tissue inflammation, transcrip-
tome analysis indicated that Hilpda expression in adipose tissue
is upregulated by high fat feeding in mice, in parallel with macro-
phage and inflammatory markers, such as Ccl2 (MCP1), Cd68,
and Itgax (Cd11c) (Figure 1B), as confirmed by qPCR (Figure 1C).
Immunohistochemistry of adipose tissue of obese mice indi-
cated that HILPDA co-localized with adipose tissue macro-
phages in crown-like structures, thus supporting the expression
of HILPDA in adipose tissuemacrophages (Figure 1D). Together,
these data suggest that HILPDA may be implicated in obesity-
induced adipose tissue inflammation and foam cell formation.
Hilpda in Macrophages Is Responsive to Lipids
To further investigate the regulation of HILPDA by lipids, we
treated RAW264.7 and primary peritoneal macrophages with
fatty acids. Confirming the transcriptomics data, oleatemarkedly1812 Cell Reports 30, 1811–1822, February 11, 2020upregulated Hilpda mRNA in RAW264.7 and peritoneal macro-
phages (Figure 1E). Similarly, intralipid significantly induced
Hilpda mRNA in both types of macrophages (Figure 1F). The
induction of HILPDA by intralipid in RAW264.7 and peritoneal
macrophages was particularly evident at the protein level (Fig-
ure 1G). Hilpda was originally identified as a hypoxia-inducible
gene 2 (Hig2) (Denko et al., 2000). Because hypoxic areas are
characteristic of obese adipose tissue (Rausch et al., 2008), we
tested the effect of a combination of intralipid and a chemical
hypoxia mimic. Together, they synergistically increased Hilpda
mRNA (Figure 1H).
Macrophage-Specific Hilpda Deficiency Impairs Lipid
Droplet Accumulation
To study the effect of HILPDA on lipid storage in macrophages,
we overexpressed HILPDA in RAW264.7 macrophages using an
adenoviral vector (Figure 1I). Interestingly, the marked increase
in HILPDA protein levels was not accompanied by any changes
in lipid droplet accumulation, as visualized by oil red O staining
(Figure 1J). These data indicate that overexpression of HILPDA
in macrophages has no discernible effect on lipid storage.
We next switched to bone-marrow-derived macrophages
(BMDMs) as a robust primary in vitro model. Similar to
RAW264.7 and peritoneal macrophages, intralipid and chemical
hypoxia synergistically upregulated Hilpda mRNA in BMDMs
(Figure 2A). To be able to study the effects of HILPDA deficiency
in macrophages, we generated mice with a myeloid-specific
Hilpda inactivation (HilpdaDMF) by crossing Hilpdaflox/flox with
mice expressing Cre-recombinase driven by the LysM promoter.
BMDMs obtained from HilpdaDMF mice and their Hilpdaflox/flox
littermates were lipid-loaded with a combination of oleate and
palmitate for 12 h to induce maximal lipid droplet formation.
The Cre-mediated excision in BMDMs led to an approximate
80% reduction in HilpdamRNA (Figure 2B) and a corresponding
decrease in HILPDA protein (Figure 2C). Strikingly, staining of
neutral lipids by boron-dipyrromethene (BODIPY) in BMDMs
showed that lipid droplets were much less visible in fatty acid-
loadedHilpdaDMF than inHilpdaflox/flox macrophages (Figure 2D).
Quantitative analysis indicated that the number of lipid droplets
per cell and the size of the lipid droplets were significantly lower
in HilpdaDMF than in Hilpdaflox/flox macrophages (Figure 2E). This
reduction of lipid droplets was confirmed by oil red O staining
(Figure 2F). In addition, triglyceride levels were markedly
decreased in fatty-acid-loaded HilpdaDMF compared with Hilp-
daflox/flox macrophages (Figures 2G and S1). Together, these
data show that HILPDA deficiency in macrophages leads to a
pronounced decrease in lipid storage.
HILPDA Does Not Regulate Fatty Acid Uptake or
Triglyceride Synthesis
We next explored potential mechanisms underlying the
decreased lipid storage in HILPDA-deficient macrophages. To
determine whether the reduction in lipid storage in HILPDA-defi-
cient macrophages is due to decreased lipid uptake, we
measured fatty acid uptake 6 and 35 min after addition of a
mixture of oleate and BODIPY-labeled C12 (BODIPY FL).
Confocal microscopy showed no difference in fluorescence in-
tensity between HilpdaDMF and Hilpdaflox/flox macrophages at 6
Figure 1. Lipid-Responsive Hilpda as Gene
of Interest in Obese Adipose Tissue
(A) Transcriptomics co-analysis of ATMs isolated
from C57BL/6 mice fed a HFD versus a LFD,
C57BL/6 mouse peritoneal macrophages treated
with oleate, and C57BL/6 Angptl4/ mouse
peritoneal macrophages treated with intralipid.
(B) Signal log-ratio of mRNA patterns of Hilpda,
inflammatory genes, and macrophage markers in
gonadal adipose tissue of C57BL/6mice fed aHFD
for 0, 1, 4, 10, or 16 weeks.
(C) Gene expression ofHilpda,Cd68, Adgre1, Itgax,
andCcl2 in gonadal adipose tissue ofC57BL/6mice
fed a HFD for 20 weeks (LFD, n = 8; HFD, n = 10).
(D) Immunohistochemical staining of HILPDA in
gonadal adipose tissue from C57BL/6 mice fed a
HFD for 20 weeks (representative data for n = 10).
Bottom panel is without primary antibody.
(E and F)HilpdamRNAexpression inRAW264.7 and
C57BL/6 mouse peritoneal macrophages exposed
to 250 mMof oleate (E) or 1mMof intralipid (F) for 6 h
versus BSA (control [Cntl]) or PBS.
(G) HILPDA protein levels in RAW264.7 and perito-
neal macrophages exposed to 1 mM of intralipid or
PBS for 6 h. ACTIN was used as the loading control.
(H) Hilpda mRNA expression in RAW264.7 and
C57BL/6 mouse peritoneal macrophages exposed
to 1 mM of intralipid or PBS in combination with
normoxia or a chemical hypoxia mimic induced by
100 mM of 2,20-bipyridyl for 6 h.
(I) HILPDAprotein levels inRAW264.7macrophages
transduced with recombinant adenovirus express-
ing Gfp (AV-Gfp) or Hilpda (AV-Hilpda) at a
multiplicity of infection of 500 for 48 h.
(J) Oil red O staining of RAW264.7 macrophages
transduced with AV-Gfp or AV-Hilpda, followed by
lipid loading with 667 mM of oleate and 333 mM of
palmitate or BSA for 24 h.
Bar graphs are presented as mean ± SEM (in vivo
studies) or mean ± SD (in vitro studies). Statistical
testing was performed by Student’s t test or by two-
way ANOVA followed by Bonferroni’s post hoc
multiple comparisons test. The effect of treatment
was significant in (H). *p < 0.05, **p% 0.01, ***p%
0.001.and 35 min (Figure 3A), which was corroborated by quantitative
image analysis (Figure 3B), indicating that HILPDA deficiency
did not influence fatty acid uptake. Expression of the fatty
acid transporter Cd36 was comparable in HilpdaDMF and
Hilpdaflox/flox macrophages (Figure 3C). In addition, the early in-
duction of gene expression by fatty acids was not different be-
tween HilpdaDMF and Hilpdaflox/flox macrophages, regardless of
whether the fatty acids were provided as free fatty acids (Fig-
ure 3D) or intralipids (Figure S2), clearly indicating that HILPDA
does not regulate fatty acid uptake. Accordingly, we hypothe-
sized that HILPDA may have two—not necessarily mutually
exclusive—functions: (1) activator of fatty acid esterification,
and/or (2) inhibitor of triglyceride lipolysis. If HILPDA acts by acti-
vating fatty acid esterification inmacrophages, suggested before
by Maier et al. (2017), it would be expected that HILPDA defi-ciencywould lead to accumulation of intermediates in the triglyc-
eride synthesis pathway. To explore that possibility, we per-
formed shotgun lipidomics on HilpdaDMF and Hilpdaflox/flox
BMDMs loaded with oleate:palmitate for 24 h. Partial least-
squares discriminant analysis clearly separated the two
genotypes (Figure 3E), indicating that the lipidomics profiles of
HilpdaDMF and Hilpdaflox/flox macrophages are very distinct. Vol-
cano plot analysis indicated that, although a number of lipids
were increased in HilpdaDMF macrophages, most lipids were
reduced (Figure 3F). Indeed, levels of phosphatidic acids, diacyl-
glycerols, and triglycerides were significantly decreased in
HilpdaDMF versus Hilpdaflox/flox macrophages (Figure 3G) as
were cholesteryl esters, whereas lysophosphatidic acids were
hardly detectable. Thedecrease in triglycerides anddiacylglycer-
ols was accounted for by the major subspecies within each lipidCell Reports 30, 1811–1822, February 11, 2020 1813
Figure 2. Myeloid-Specific HILPDA Defi-
ciency Decreases Lipid Droplet Accumula-
tion
(A) Hilpda mRNA expression in C57BL/6 BMDMs
exposed to 1 mM of intralipid or PBS, combined
with normoxia or chemical hypoxia induced by
100 mM of 2,20-bipyridyl for 6 h.
(B and C) Gene expression of Hilpda (B) and
protein levels of HILPDA (C) in Hilpdaflox/flox and
HilpdaDMF BMDMs lipid loaded with 400 mM of
oleate and 200 mM of palmitate (OA:PA, Fatty
acids) or BSA (Cntl) for 12 h (n = 3). HSP90 was
used as loading control.
(D–F) BODIPY (D and E) and oil red O (F) staining in
Hilpdaflox/flox and HilpdaDMF BMDMs lipid loaded
with oleate:palmitate or BSA (Cntl) for 24 h. Data
are shown from or are representative of at least
three independent experiments.
(G) Triglyceride measurement in BMDMs from
Hilpdaflox/flox and HilpdaDMF lipid loaded with
oleate:palmitate or BSA (Cntl) for 6 or 12 h. See
also Figure S1.
Bar graphs are presented as mean ± SD.
Statistical testing was performed by Student’s
t test or by two-way ANOVA followed by
Bonferroni’s post hoc multiple comparisons test.
The effect of treatment was significant in (A), (B)
and (G). *p < 0.05, ***p % 0.001. LD, lipid droplet;
OA:PA, oleate:palmitate.class (Figure 3H). Thesedata suggest thatHILPDAprobably does
not regulate the fatty acid esterificationpathway inmacrophages.
HILPDA Regulates Lipid Droplet Mobilization through
ATGL Inhibition
To further investigate the molecular basis for the decreased lipid
storage in HILPDA-deficient macrophages, we determined the
trafficking of lipids after loading with a mixture of oleate and
BODIPY FL for either 5 or 24 h. Strikingly, after lipid loading
Hilpdaflox/flox macrophages for 5 h, the BODIPY FL had largely
accumulated in lipid droplets, whereas in HilpdaDMF macro-
phages, the BODIPY FL was mainly distributed throughout the
endoplasmic reticulum (ER) and showed only minor presence
in lipid droplet-like structures (Figure 4A). After lipid loading for
24 h, the size and number of lipid droplets had further increased
in Hilpdaflox/flox macrophages, whereas in HilpdaDMF macro-
phages, the lipid-droplet-like structures that had initially formed
at 5 h were no longer visible (Figure 4A). These data indicate that
HilpdaDMF BMDMs, although able to take up similar amounts of
fatty acids as Hilpdaflox/flox BMDMs, are unable to retain them
in lipid droplets.
Using various biochemical and cellular assays, we and others
previously found that HILPDA is able to inhibit ATGL, the rate-
limiting enzyme for lipolysis (Zhang et al., 2017; Padmanabha
Das et al., 2018). However, it is unclear whether HILPDA is a phys-
iological regulator of ATGL in macrophages. To investigate
whether thedecrease in lipiddroplet and triglycerideaccumulation
in HilpdaDMF macrophages is due to enhanced ATGL-mediated
lipolysis, we loaded HilpdaDMF and Hilpdaflox/flox BMDMs with
oleate:palmitate in the presenceofAtglistatin, a small-molecule in-
hibitor of ATGL (Mayer et al., 2013). Strikingly, inhibiting ATGL1814 Cell Reports 30, 1811–1822, February 11, 2020markedly increased lipid droplets in HilpdaDMF BMDMs (Fig-
ure 4B), almost completely rescuing the HilpdaDMF phenotype.
Quantitative analysis showed that the lipid droplet surface area
wasnotsignificantlyaffectedbyAtglistatin inHilpdaflox/floxBMDMs
and markedly increased by Atglistatin in HilpdaDMF BMDMs (Fig-
ure S3A). Similarly, the defective retention of BODIPY FL in lipid
droplets inHilpdaDMFmacrophages was almost completely abol-
ished by Atglistatin (Figures 4C and S3B). These studies indicate
that the decrease in lipid droplet and triglyceride accumulation in
HilpdaDMF macrophages is caused by accelerated lipid droplet
breakdown via enhanced ATGL-mediated lipolysis. Our data
thus suggest that HILPDA functions as a potent endogenous
inhibitor of ATGL in macrophages.
To determine whether HILPDA may influence the abundance
of ATGL and other lipid droplet-associated proteins in
macrophages, we performed western blot on HilpdaDMF and
Hilpdaflox/flox BMDMs loaded with oleate:palmitate for 24 h. As
expected, lipid loading increased HILPDA levels as well as
PLIN3 levels (Figure 4D). Remarkably, ATGL levels weremarkedly
higher inHilpdaDMF than inHilpdaflox/flox BMDMs, suggesting that
HILPDA not only inhibits ATGL but also decreases ATGL protein
levels. G0S2 protein levels, despite being difficult to detect,
were also higher in HilpdaDMF than in Hilpdaflox/flox BMDMs.
HILPDA Deficiency Promotes Respiration
If lipolysis is enhanced, the free fatty acid levels in the cell may
rise, thereby stimulating fatty-acid-dependent gene regulation.
Consistent with this notion, the expression of fatty-acid-induc-
ibleGdf15,Cpt1a, and Il7rwas significantly higher in lipid-loaded
HilpdaDMF than in Hilpdaflox/flox BMDMs (Figure 5A). To analyze
that further, we performed transcriptomics on HilpdaDMF and
Figure 3. HILPDA Does Not Regulate Fatty
Acid Uptake or Triglyceride Synthesis
(A) Confocal microscopy of Hilpdaflox/flox and
HilpdaDMF BMDMs incubated with BODIPY FL for
6 or 35 min.
(B) Fluorescence quantification reflecting fatty acid
uptake.
(C) Cd36 mRNA in Hilpdaflox/flox and HilpdaDMF
BMDMs.
(D) Gene expression of Hilpda, Ddit3, Ptgs2, and
Plin2 in BMDMs from Hilpdaflox/flox and HilpdaDMF
lipid loaded with oleate:palmitate or BSA (Cntl) for
6 h (n = 3). See also Figure S2.
(E–H) Partial least-square discriminant analysis (E);
volcano plot analysis (F); differences in abundancy
of cholesteryl esters (CE), diacylglycerol (DAG),
phosphatidic acid (PA), triacylglycerol (TAG), and
total lipid species (G); and heatmap of most-
abundant DAG and TAG species (H) based on
shotgun lipidomics on Hilpdaflox/flox and HilpdaDMF
BMDMs loaded with oleate:palmitate for 24 h.
Bar graphs are presented as mean ± SD. Statisti-
cal testing was performed by Student’s t test or by
two-way ANOVA followed by Bonferroni’s post
hoc multiple comparisons test. The effect
of treatment was significant in (C). *p < 0.05,
***p% 0.001. SLR, signal log ratio.Hilpdaflox/flox BMDMs loaded with oleate:palmitate for 24 h and
co-analyzed the data together with a transcriptomics dataset
of Robblee et al. (2016) on wild-type BMDMs loaded with stea-
rate for 20 h, as well as with the transcriptomics dataset of
adipose tissue macrophages from obese and lean mice. In line
with enhanced fatty-acid-dependent gene regulation in
Hilpda-deficient macrophages, genes that were highly upregu-
lated after stearate in wild-type BMDMs, such as Gdf15, Il7r,
and Ddit3, were also higher in fatty-acid-loaded HilpdaDMF
than Hilpdaflox/flox BMDMs (Figure 5B). In addition, pro-inflam-
matory genes, such as Ccl2 and Il1b, were downregulated by
stearate in wild-type BMDMs and were also lower in fatty-acid-
loaded HilpdaDMF compared with Hilpdaflox/flox BMDMs. Inter-
estingly, genes induced by obesity in adipose tissue macro-
phages, such as Lpl, Lipa, and Itgax, were only weakly regulated
by stearate and by HILPDA deficiency, suggesting distinct
regulatory mechanisms (Figure 5B).Cell RepoOf the 6,600 genes that passed the
expression threshold, only 49 were
induced more than 2-fold in fatty-acid-
loaded HilpdaDMF compared with
Hilpdaflox/flox BMDMs. The limited effect
of impaired triglyceride retention in
HilpdaDMF BMDMs suggests that the
excess fatty acids may be disposed of,
for instance, by enhanced oxidation. To
explore that option, cellular respiration
was determined in fatty-acid-loaded
HilpdaDMF and Hilpdaflox/flox BMDMs. As
a marker for oxidative phosphorylation,
oxygen consumption of fatty-acid-loadedHilpdaDMF andHilpdaflox/flox BMDMs was measured by extracel-
lular flux analysis during a mitochondrial stress test (Figure 5C).
After 6 h of oleate:palmitate loading, basal and maximal respira-
tion were slightly lower in HilpdaDMF than in Hilpdaflox/flox
BMDMs (Figure 5D). Remarkably, however, after 24 h of fatty
acid loading, basal and maximal respiration were significantly
higher in HilpdaDMF compared with Hilpdaflox/flox BMDMs (Fig-
ure 5D), indicating an increased maximal oxidative capacity.
These data suggest that the enhanced lipolysis in HilpdaDMF
BMDMs is accompanied by increased fatty acid oxidation
through oxidative phosphorylation.
Next, we tested whether HILPDA might influence lipid droplet
accumulation in macrophages in adipose tissue. To mimic the
adipose environment in vitro, BMDMs were treated with condi-
tioned medium of adipose tissue explants. Adipose-conditioned
medium markedly increased Hilpda expression, along with that
of several other lipid-sensitive genes, such as Plin2, Cd36, andrts 30, 1811–1822, February 11, 2020 1815
Figure 4. HILPDA Regulates Lipid Droplet
Mobilization through ATGL Inhibition
(A) Fatty acid trafficking in Hilpdaflox/flox and
HilpdaDMF BMDMs lipid-loaded with oleate and
BODIPY FL for 5 or 24 h.
(B) BODIPY staining inHilpdaflox/flox andHilpdaDMF
BMDMs lipid-loaded with oleate:palmitate for 24 h
and treated with 20 mM of Atglistatin or vehicle.
(C) Fatty acid trafficking in Hilpdaflox/flox and
HilpdaDMF BMDMs lipid-loaded with oleate and
BODIPY FL for 24 h and treated with 20 mM of
Atglistatin or vehicle.
(D) Protein expression of selected lipid droplet-
associated proteins in Hilpdaflox/flox and HilpdaDMF
BMDMs lipid-loaded with oleate:palmitate or BSA
for 12 h.
LD, lipid droplet.
See also Figure S3.Angptl4 (Figure 5E). Consistent with our previous studies with
fatty-acid-loaded macrophages, HilpdaDMF BMDMs incubated
with adipose-conditioned medium showed substantially
reduced BODIPY staining compared with Hilpdaflox/flox BMDMs
(Figure 5F). These data suggest that HILPDA may also influence
lipid droplet accumulation in macrophages in adipose tissue.
Myeloid-Specific Deficiency of HILPDA Decreases Lipid
Droplets in Adipose Tissue Macrophages (ATMs)
without Altering Adipose Tissue Inflammation
To enable studying the effect of HILPDA deficiency in macro-
phages in vivo, we used HilpdaDMF mice and their Hilpdaflox/flox
littermates. As expected, myeloid-specific inactivation of Hilpda
significantly decreasedHilpda expression in the stromal vascular
fraction of the adipose tissue but not in the adipocyte fraction1816 Cell Reports 30, 1811–1822, February 11, 2020(Figure 6A). To test the functional conse-
quences of macrophage HILPDA defi-
ciency in the context of obesity-induced
adipose tissue inflammation and foam
cell formation, HilpdaDMF mice and their
Hilpdaflox/flox littermates were rendered
obese and insulin resistant by high fat
feeding for 20 weeks, using a low-fat
diet as control. Bodyweight gain (Fig-
ure 6B), feed intake (Figure 6C), and liver
and adipose tissue weights (Figure 6D)
were not different between HilpdaDMF
and Hilpdaflox/flox littermates. Consistent
with the data shown in Figure 1C, high-
fat feeding increased Hilpda mRNA in
adipose tissue. Interestingly, the relative
increase in Hilpda mRNA was consider-
ably lower in HilpdaDMF than it was in
Hilpdaflox/flox adipose tissue (Figure 6E),
suggesting that the increase in Hilpda
expression by high-fat feeding is mainly
driven by its expression in macrophages.
Immunoblot for HILPDA confirmed that
notion by showing markedly reducedHILPDA protein levels in HilpdaDMF versus Hilpdaflox/flox adipose
tissue (Figure 6F).
Based on the studies in BMDMs, we hypothesized that lipid
accumulation would be reduced in adipose tissue macrophages
from HilpdaDMFmice compared with Hilpdaflox/flox mice. Indeed,
oil red O staining showed significantly lower lipid droplet content
in adipose tissuemacrophages isolated from high-fat diet (HFD)-
fed HilpdaDMF mice compared with HFD-fed Hilpdaflox/flox mice
(Figures 7A and 7B). Interestingly, however, the decrease in lipid
droplets was not associated with any change in the secretion of
the classical inflammatory cytokines interleukin-6 (IL-6) and
tumor necrosis factor alpha (TNF-a) (Figure 7C). These data
indicate that HILPDA deficiency reduces lipid accumulation in
adipose tissue macrophages but does not have any effect on
their ex vivo inflammatory properties.
Figure 5. Loss of ATGL Inhibition by HILPDA
Deficiency Does Not Affect Lipid-Induced
Inflammation but Increases Oxidative
Respiration
(A) Gene expression of Gdf15, Cpt1a, Il7r, and
Fabp4 in Hilpdaflox/flox and HilpdaDMF BMDMs
lipid-loaded with oleate:palmitate or BSA (Cntl) for
12 h (n = 3).
(B) Microarray-based gene expression of relevant
genes in wild-type (WT) C57BL/6 mouse BMDMs
loaded with stearate (250 mM) for 20 h, HilpdaDMF
BMDMs loaded with oleate:palmitate for 24 h, and
adipose tissue macrophages isolated from mice
fed a HFD versus a LFD.
(C and D) Oxygen consumption rate of
Hilpdaflox/flox and HilpdaDMF BMDMs lipid-loaded
with oleate:palmitate or BSA (Cntl) for 6 or 24 h (C)
and corresponding basal and maximal respiration
levels (D). Data are representative of three
independent experiments.
(E and F) Gene expression levels of Hilpda, Plin2,
Angptl4, and Cd36 in C57BL/6 mouse BMDMs
loaded with adipose-conditioned medium (CM) or
Cntl for 6 h (E) and BODIPY staining after loading
with CM for 24 h (F) (n = 3).
Bar graphs are presented as mean ± SD.
Statistical testing was performed by Student’s
t test or by two-way ANOVA followed by
Bonferroni’s post hoc multiple comparisons test.
The effect of treatment was significant in (A) and
(D). *p < 0.05, **p % 0.01, ***p % 0.001. FA, fatty
acid loading with oleate:palmitate; SLR, signal log
ratio.To investigate the potential effect of macrophage HILPDA on
adipose tissue inflammation in vivo, we performed flow cytometry
analysis of the stromal vascular fraction isolated from the adipose
tissue of the various groups of mice. The results showed an
increased percentage of populations of CD45+, CD11b+CD206+,
and CD11b+CD11c+ cells by high-fat feeding, but no clear
differences in the percentages of those populations between
HilpdaDMF and Hilpdaflox/flox mice (Figure 7D). To further examine
the influence of macrophage HILPDA deficiency on inflammation
in adipose tissue,wedetermined theexpressionof selectedgenes.
Interestingly, mRNA levels of both inflammatory macrophage
marker Itgax (Cd11c) and general macrophage marker Cd68
were significantly lower in adipose tissue ofHilpdaDMFmice versus
Hilpdaflox/flox mice fed a HFD (Figure 7E), whereas the general
macrophage marker Adgre1 (F4/80) showed a trend toward a
decreased expression (Figure S4). Despite being induced by
high-fat feeding, adipose expression of other pro- or anti-inflam-
matory genes, such as Gdf15, Il10, Arg1, Ccl2, and Il1ra, was not
significantly different between HilpdaDMF and Hilpdaflox/flox mice
(Figure S4). Expression ofAdipoq and Leptin alsowas not different
between HilpdaDMF and Hilpdaflox/flox mice (Figure S4).
To further investigate the inflammatory status of adipose
tissue, the density of crown-like structures was determined in
adipose tissue of HilpdaDMF and Hilpdaflox/flox mice fed a HFD.
A trend toward lower density was found in the HilpdaDMF mice
(Figure 7F), which, however, did not reach statistical significance
(Figure 7G). Additionally, we measured the ex vivo release ofcytokines from adipose tissue explants. Although high-fat
feeding stimulated the release of IL-10 and IL-6, no significant
difference in IL-10 and IL-6 release was observed between
adipose tissue explants from HilpdaDMF and Hilpdaflox/flox mice
(Figure 7H).
Finally, to determine whether macrophage HILPDA deficiency
has any influence on obesity-induced metabolic derailments, we
measured plasma metabolic parameters and assessed glucose
tolerance in HilpdaDMF and Hilpdaflox/flox mice fed the low- and
high-fat diets. High-fat feeding significantly increased plasma
levels of cholesterol, triglycerides, glucose, non-esterified fatty
acids, leptin, and insulin (Figure S5). However, no differences
in those parameters were observed between HilpdaDMF and
Hilpdaflox/flox mice, either on a low- or high-fat diet (Figure S5).
Similarly, although high-fat feeding caused a marked decrease
in glucose tolerance, no differences were observed between
HilpdaDMF and Hilpdaflox/flox mice (Figure 7I).
Collectively, our data indicate that myeloid-specific HILPDA
deficiency reduces lipid droplet accumulation in adipose tissue
macrophages but does not influence the inflammatory status
of adipose tissue and does not have any effect on obesity-
induced metabolic complications.
DISCUSSION
Here, we show that HILPDA deficiency in macrophages disrupts
stable lipid droplet formation after lipid loading. The reduction inCell Reports 30, 1811–1822, February 11, 2020 1817
Figure 6. Hilpda Deficiency in Myeloid Cells
Results in a Decrease in HILPDA in Gonadal
White Adipose Tissue (gWAT) after High-Fat
Feeding, without Influencing Body and
Organ Weight
(A) Relative gene expression of Hilpda in whole
gWAT, stromal vascular fraction, and adipocyte
fraction ofHilpdaflox/flox andHilpdaDMFmice (n = 3–
7).
(B–F) Body weight (B), feed intake (C), and weight
of liver, inguinal white adipose tissue (iWAT),
gWAT, and BAT (D) in Hilpdaflox/flox and HilpdaDMF
mice fed a LFD or a HFD for 20 weeks.Hilpda gene
expression in gWAT (E) and HILPDA protein
expression in gWAT (F).
Bar graphs are presented as mean ± SEM,
(n = 10–12 mice per group). Statistical testing was
performed by Student’s t test or by two-way
ANOVA followed by Bonferroni’s post hoc multiple
comparisons test. The effect of diet was significant
in (C), (D), and (E). *p < 0.05, ***p % 0.001. BAT,
brown adipose tissue; gWAT, gonadal adipose
tissue; iWAT, inguinal adipose tissue; SVF, stromal
vascular fraction.lipid droplets is caused by impaired retention of lipids because of
elevated ATGL-mediated lipolysis, which, in turn, is associated
with increased oxidative metabolism (Figure S6). Overall, our
data demonstrate that HILPDA is an endogenous and physiolog-
ical inhibitor of ATGL in macrophages. Strikingly, despite
reducing lipid storage in adipose tissue macrophages, HILPDA
deficiency in macrophages does not alter the inflammatory sta-
tus of adipose tissue in diet-induced obesity, arguing against the
notion that lipid droplet accumulation in adipose tissue
macrophages promotes adipose tissue inflammation and asso-
ciated metabolic complications, such as insulin resistance.
During obesity, macrophages infiltrate the adipose tissue and
take up adipocyte-released lipids. The resulting lipid-laden
macrophages are found in crown-like structures inmurine and hu-
manobesity (Lumenget al., 2008; Prieur et al., 2011; Shapiro et al.,
2013). These macrophages form a distinct subpopulation with a
characteristic activation that is likely triggered by the adipocyte-
released lipids (Kratz et al., 2014; Coats et al., 2017; Hill et al.,
2018). Because lipid droplet formation often serves as a cytopro-
tective mechanism to prevent lipotoxicity by lipid intermediates or
free fatty acids (Saraswathi and Hasty, 2009), it could be hypoth-
esized that the enhanced lipid droplet breakdown in HILPDA-defi-
cientmacrophagesmay result in elevated inflammation.However,
HILPDA deficiency not only reduced intracellular triglyceride
levels but also the levels of potentially lipotoxic intermediates,
such as diacylglycerols, likely via enhanced fatty acid oxidation,
whichmay be predicted to lead to reduced inflammation (Namga-
ladze and Br€une, 2016). Intriguingly, however, no clear effect of
HILPDA deficiency was observed on cytokine release by adipose
tissue macrophages, on the percentage of different macrophage
populations in adipose tissue, on inflammatory gene expression in
adipose tissue, and on cytokine release by adipose tissue
explants. In addition, genes typically elevated in adipose tissue1818 Cell Reports 30, 1811–1822, February 11, 2020macrophages of obese mice, such as Lipa, Lpl, and Itgax, were
not induced by fatty acid loading or altered by HILPDA deficiency.
The data argue against the notion that excessive lipid droplet
accumulation in adipose tissue macrophages is the major driver
of adipose tissue inflammation and of the composition of
macrophage populations in obese adipose tissue. Rather, the
unique profile of adipose tissuemacrophagesmay be determined
by other factors active in the obese adipose tissue environment,
the identity of which requires further study.
As indicated above, HILPDA-deficient macrophages
exhibited a marked decrease in intracellular levels of all the ma-
jor lipid species, including triglycerides, diacylglycerols, phos-
phatidic acids, and cholesteryl esters, likely because of
enhanced fatty acid oxidation. Previously, a strong link was
made between ATGL activity and fatty acid oxidation in liver
and heart. It was found that ATGL-mediated lipolysis activates
a transcriptional network involving PGC-1a/PPAR-a that
controls fatty acid oxidation and mitochondrial biogenesis
(Reid et al., 2008; Sapiro et al., 2009; Haemmerle et al., 2011;
Ong et al., 2011). Accordingly, it is likely that the loss of ATGL
inhibition is directly responsible for the enhanced oxidative
capacity, reducing the total intracellular lipid levels. In general,
increased lipolysis and increased oxidative respiration are two
traits essential for macrophage polarization toward alternative,
M2-like phenotypes, which may be protective in the context of
adipose tissue inflammation (Huang et al., 2014; Van den Bos-
sche et al., 2016; Jung et al., 2018). In our experiments,
increased oxidative respiration seemed a mere consequence
following overactive ATGL-mediated lipolysis and did not
contribute to any anti-inflammatory effects. Although increased
oxidation of fatty acids is often proposed as an alternative
cytoprotective pathway in lipid-laden macrophages, the inter-
play between fatty acid oxidation, concomitant reactive oxygen
Figure 7. Myeloid-Specific Deficiency of
Hilpda Decreases Lipid Droplets in ATMs
without Altering Adipose Tissue Inflamma-
tion or Glucose Tolerance
(A) Oil red O staining of adipose tissue macro-
phages isolated from Hilpdaflox/flox and HilpdaDMF
mice fed a HFD for 20 weeks.
(B) Quantification of Oil red O staining. Data are
mean ± SD.
(C) Corrected TNF-a and IL-6 secretion of adipose
tissue macrophages from Hilpdaflox/flox and
HilpdaDMFmice fed a HFD for 20 weeks (n = 10–12
per group, pooled per 3–4).
(D) Flow-cytometry-based percentages of CD45+,
CD45+F4/80+, CD11b+CD206+, and CD11b+
CD11c+ populations in the SVF of gWAT from
Hilpdaflox/flox andHilpdaDMFmice (n = 10–12, pooled
per 3–4).
(E) Gene expression of Itgax, Adgre1, Cd68, Ccl2,
Il10, and Il1ra; see also Figure S4.
(F–H) Density of CLSs in gWAT coupes stained for
F4/80 from Hilpdaflox/flox (F) and HilpdaDMF (G) mice
(only for HFD) and secretion of IL-6 and IL-10 (H) in
gWAT explants (n = 10–12 per group).
(I) Glucose tolerance test after 18 weeks of LFD or
HFD feeding; see also Figure S5.
Bar graphs are presented as mean ± SEM,
(n = 10–12 mice per group). Statistical testing was
performed by Student’s t test or by two-way ANOVA
followed by Bonferroni’s post hoc multiple compar-
isons test. The effect of diet was significant in (D), (E),
(H), and the AUCs of (I). *p < 0.05, **p% 0.01, ***p%
0.001. AUC, area under the curve; CLS, crown-like
structure; SVF, stromal vascular fraction; .species (ROS) formation, and ER stress complicates this
mechanism (Namgaladze and Br€une, 2016).
Apart from fatty acid oxidation, ATGL has also been linked to
the autophagic degradation of lipid droplets, termed lipophagy
(Sathyanarayan et al., 2017). It was suggested that ATGL acts
as a signaling node to promote lipophagy, which then controls
bulk lipid-droplet breakdown. Whether HILPDA, via ATGL,
connects to lipophagy requires further study.
In contrast to the cytoprotective effect of normal lipid droplet
formation, the adverse effects of excessive triglyceride storage
becomes apparent in ATGL/ macrophages, underlining the
importance of functional ATGL in macrophages (Chandak et al.,
2010; Aflaki et al., 2011a, 2011b, 2012). Indeed, the elevated
triglyceride accumulation in ATGL/ macrophages is accompa-
nied by mitochondrial dysfunction and apoptosis, ER stress,
reduced macrophage migration, and decreased phagocytosis
ability (Chandak et al., 2010; Aflaki et al., 2011a, 2011b, 2012),
suggesting that proper macrophage function is dependent on
the liberation of free fatty acids from intracellular triglyceride
stores. The ATGL-mediated release of fatty acids is also neces-
sary for the production of lipid mediators, at least in neutrophils
(Schlager et al., 2015). Similar to ATGL/ macrophages, macro-
phages deficient in the ATGL activator CGI-58 (also known asCell RepoABHD5) also have elevated lipid storage
and decreased phagocytic capacity but
show no signs of mitochondrial apoptosisand ER stress, suggesting that triglyceride accumulation per se
does not drive mitochondrial dysfunction (Goeritzer et al., 2014).
Our data show that HILPDA deficiency, despite leading to mark-
edly reduced lipid storage, raises markers of ER stress, suggest-
ing that triglyceride storage protects against lipid-induced ER
stress. Presumably, the mechanism leading to ER stress is
different in HILPDA-deficient macrophages as compared with
ATGL/CGI-58-deficient macrophages.
HILPDA was initially identified in a screen for hypoxia-induc-
ible genes in human cervical cancer cells and was later found
to be associated with lipid droplets (Denko et al., 2000; Gimm
et al., 2010). We identified Hilpda as a novel PPARa target
gene in liver (Mattijssen et al., 2014). In addition, Hilpda is well
expressed in adipocytes (DiStefano et al., 2016; Dijk et al.,
2017). Several studies have shown that overexpression ofHilpda
increases intracellular lipid storage in cells (Gimm et al., 2010;
Mattijssen et al., 2014; Dijk et al., 2017). In the present study,
Hilpda emerged from a screen for genes elevated by obesity in
adipose tissue macrophages and upregulated in macrophages
by fatty acids. Induction of HILPDA by fatty acids and subse-
quent inhibition of triglyceride hydrolysis is likely part of a lipid-
buffering effort of the cell to effectively store excess energy
and neutralize the potentially reactive free fatty acids (Figure S6).rts 30, 1811–1822, February 11, 2020 1819
The observation that the decrease in lipid storage in HILPDA-
deficient macrophages can be almost completely abolished by
inhibition of ATGL indicates that HILPDA is an endogenous inhib-
itor of ATGL in macrophages, which is in line with previous data
showing direct inhibition of ATGL by HILPDA (Zhang et al., 2017;
Padmanabha Das et al., 2018). Intriguingly, HILPDA reduced
ATGL protein levels in BMDMs, which supports our previous
finding that HILPDA reduces ATGL protein levels in 3T3-L1 adi-
pocytes (Dijk et al., 2017). It can be hypothesized that binding of
HILPDA to ATGL might destabilize it, leading to enhanced ATGL
degradation. This option should be investigated in future
experiments. Of note, our observation that forced upregulation
of HILPDA levels in macrophages does not noticeably increase
lipid-droplet accumulation suggests that inhibition of ATGL is
nearly maxed out in lipid-loaded macrophages.
The inhibition of ATGL by HILPDA is analogous to the inhibition
by G0/G1 switch gene 2 (G0S2), with which HILPDA shares
extensive sequence homology (Yang et al., 2010; Zhang et al.,
2017; Padmanabha Das et al., 2018). However, the inhibitory
potency of HILPDA was low compared with G0S2, which raised
questions on the physiological relevance of HILPDA as an ATGL
inhibitor. Our studies demonstrate that HILPDA is a potent
endogenous inhibitor of ATGL-mediated lipolysis in macro-
phages. A number of questions emerge from this work. First,
why does HILPDA, despite allegedly being a much weaker
ATGL inhibitor than G0S2, have such a marked influence on lipid
storage in macrophages? We hypothesize that HILPDA may
require an interaction with an auxiliary factor for full activity.
Further research is necessary to identify the mechanism for the
differential potency of HILPDA in cell-free systems compared
with live cells. Second, what is the reason for having two related
ATGL inhibitors? Although our preliminary data suggest that in
BMDMs, HILPDA is much more abundant than G0S2; it seems
that in certain cells, such as cultured hepatocytes, HILPDA and
G0S2 co-exist. Inasmuch as HILPDA and G0S2 are induced by
different stimuli, they may be active under different circum-
stances. So far, there is no evidence for any functional depen-
dency between the two proteins. Further research is necessary
to better characterize the relationship and relative roles of these
two homologous proteins in different cell types.
In conclusion, our data demonstrate that HILPDA is a lipid-
inducible, physiological inhibitor of ATGL-mediated lipolysis in
macrophages. In obese mice, HILPDA uncouples lipid droplet
accumulation in adipose tissue macrophages from inflammation
and metabolic dysregulation. Overall, our data question the
importance of lipid storage in adipose tissue macrophages in
obesity-induced inflammation and metabolic dysregulation.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal Studies
Studies were performed using purebred wild-type C57BL/6 mice, HilpdaDMF mice and their Hilpdaflox/flox littermates. Hilpdaflox/flox
were acquired (Jackson Laboratories, Bar Harbor, ME; Hilpdatm1.1Nat/J, JAX: #017360, RRID: MGI:5285399) and backcrossed
onto a C57BL/6 background in our facility for at least 5 generations. LysM-Cre transgenic mice (B6.129P2-Lyz2tm1(cre)Ifo/J,
JAX:#004781, RRID: IMSR_JAX:004781) were acquired from Jackson laboratories. Prior to arrival at Jackson laboratories, the
lysM-Cre transgenic mice have been backcrossed onto a C57BL/6 background for at least six generations. In our facility, the
Hilpdaflox/flox were crossed with lysM-Cre transgenic mice to generate mice with a mature myeloid cell-specific Cre-mediated
deletion of Hilpda on a C57BL/6 background. The identity of the C57BL/6 background strain was not confirmed by sequencing.
Mice were individually housed under normal light-dark cycles in temperature- and humidity-controlled specific pathogen-free
conditions. Mice had ad libitum access to food and water. The experimenter was blinded to group assignments during all analyses.
For in vivo studies, male mice were used with an age of 9-12 weeks. For the isolation of primary cell cultures, both male and female
mice were used with an age of 8-12 weeks. All animal experiments were approved by the local animal welfare committee of
Wageningen University (AVD104002015236, 2016.W-0093.001).
Cell Lines and Primary Cultures
RAW264.7 macrophage cells (Cat#91062702; RRID: CVCL_0493, Sigma-Aldrich, Darmstadt, Germany) and bone-marrow derived
macrophages were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Corning, NY, USA), supplemented with 1%
penicillin/streptomycin (P/S, Corning). Adipose tissue macrophages and peritoneal macrophages were cultured in Roswell Park
Memorial Institute (RPMI)-1630 medium (Lonza, Basel, Zwitserland) supplemented with 10% FCS and 1% P/S. All cells were kept
in incubators at 37C/5% CO2. Primary cell cultures were isolated from male and female wild-type C57BL/6, Hilpda
DMF and
Hilpdaflox/flox mice aged 8-12 weeks. RAW264.7 macrophages were purchased as authenticated cell line from Sigma-Aldrich.e2 Cell Reports 30, 1811–1822.e1–e6, February 11, 2020
METHOD DETAILS
Mouse Studies
Per genotype, 12 male HilpdaDMF mice aged 9-12 weeks or their male Hilpdaflox/flox littermates were randomly allocated using an
online randomization tool to either a standardized high fat diet or a low fat diet (formula D12451 and formula D12450H respectively,
Research Diets, New Brunswick, USA; g-irradiated with 10-20 kGy) for 20 weeks. Body weight and feed intake were assessed
weekly. At the end of the study, mice were anaesthetised with isoflurane and blood was collected via orbital puncture in tubes
containing EDTA (Sarstedt, N€umbrecht, Germany). Subsequently, mice were immediately euthanized by cervical dislocation, after
which tissues were excised, weighed and frozen in liquid nitrogen or prepared for histology. Frozen samples were stored at 80C.
Intraperitoneal Glucose Tolerance Test
In the HFD-LFD study, an intraperitoneal glucose tolerance test was performed after 18 weeks. Mice were fasted for 5 hours and
blood was collected via tail bleeding at 0, 15, 30, 45, 60, 90 and 120 minutes after i.p. injection of 1g/kg bodyweight glucose (Baxter,
Deerfield, IL, USA). Blood glucose was measured with a GLUCOFIX Tech glucometer and glucose sensor test strips (GLUCOFIX
Tech, Menarini Diagnostics, Valkenswaard, the Netherlands). A time point of 150 minutes after injection of glucose was added for
the high fat diet fed groups.
Plasma Measurements
Blood collected in EDTA tubes was spun down for 15 minutes at 5000 RPM at 4C. Plasma was aliquoted and stored at 80C until
measurement of cholesterol (Liquicolor, Human GmbH,Wiesbaden, Germany), triglycerides (Liquicolor), glucose (Liquicolor), NEFAs
(NEFA-HR set R1, R2 and standard, WAKO Diagnostics, Instruchemie, Delfzijl, the Netherlands), adiponectin (ELISA duoset kit, R&D
Systems, Bio-techne, MN, USA), leptin (ELISA duoset kit, R&D Systems) and insulin (ultra-sensitive mouse insulin ELISA kit, Crystal
Chem Inc., IL, USA) following manufacturer’s instructions.
gWAT Explants and Adipose Macrophage Isolation
For SVF, adipocytes and adipose tissue macrophages isolation, gonadal adipose tissue (gWAT) was collected and kept in with
DMEM supplemented with 1%P/S and 1%FFA-free Bovine Serum Albumin (BSA fraction V, Roche via Merck, Darmstadt, Germany)
on ice. gWAT explants were taken into culture for 24h in DMEM, supplemented with 10% fetal calf serum (FCS, BioWest, Nuaille´,
France) and 1% P/S. Supernatant was stored for ELISA measurements or as conditioned medium. For high fat diet groups, the
stromal vascular fractions were isolated by digesting gWAT for 45 minutes in Roswell Park Memorial Institute (RPMI)-1630 medium
(Lonza, Basel, Zwitserland) supplemented with 10% FCS, 1% P/S, 0.5% FFA-free BSA, 1M CaCl2, 1M HEPES and 0.15% collage-
nase (from Clostridium histolyticum, Sigma-Aldrich, Cat#C6885; CAS: 9001-12-1). Per three mice of the same group, gWAT was
pooled after digestion, filtered through a 100mm cell strainer and centrifuged at 200 g for 10 min. Floating mature adipocytes
were removed and stored separately and stromal vascular pellet was resuspended in erythrocyte lysis buffer and subsequently
washed twice in phosphate buffered saline (PBS, Corning) supplementedwith 0.5%FFA-free BSA and 2mMEDTA. Resulting stromal
vascular fractions were used to isolate ATMs using mouse anti-F4/80-FITC antibodies (Cat#130-117-509; RRID: AB_2727970,
Miltenyi Biotec, Bergisch Gladbach, Germany), anti-FITC MicroBeads (Cat#130-048-701; RRID: AB_244371, Miltenyi Biotec) and
MS columns (Miltenyi Biotec) on an OctoMACS Cell Separator system (Miltenyi Biotec). ATMs were cultured for 24h in RPMI-
1630 supplemented with 10% FCS and 1% P/S. ATMs were either cultured for 2h after which cells were washed with PBS, fixed
in 3.7% paraformaldehyde and stained with Oil red O following standard protocols, or were cultured for 24h to obtain supernatants.
Flow Cytometry of SVF
Before isolation of ATMs, SVF pools were resuspended in PBS containing 0.5%BSA and 2mMEDTA and 500 000 cells were sampled
and stained with antibodies against CD45-ECD (Cat#A07784, Beckman Coulter, Brea, CA, USA), F4/80-FITC (Cat#123107; RRID:
AB_893500), CD206-APC (Cat#141707; RRID: AB_10896057), CD11c-PE-Cy7 (Cat#117317; RRID: AB_493569) and CD11b-PE
(Cat#101207; RRID: AB_312790, Biolegend, San Diego, CA, USA). Samples were measured on a flow cytometer (FC500, Beckman
Coulter) and results were analyzed using Kaluza analysis software 2.1 (RRID: SCR_016182, Beckman Coulter).
Histological Studies
Samples of gWAT for histological analysis were fixed in 3.7% paraformaldehyde immediately upon collection, embedded in paraffin,
sectioned and stained with hematoxylin eosin according to standard protocols. After preincubation with 20% normal goat serum,
paraffin-embedded sections were incubated at 4C overnight with antibodies for F4/80 (Cat#MCA497G; RRID: AB_872005, Bio-
Rad Laboratories, Hercules, CA, USA), HILPDA (sc-137518 HIG2 Antibody (C-14); RRID: AB_2011522, Santa-Cruz Biotechnology,
Dallas, TX, USA Biotechnology) or CD68 (Cat#MCA1957; RRID: AB_322219, AbD Serotec, Bio-Rad Laboratories) dissolved in PBS
supplemented with 1% BSA (Merck). Anti-rat or anti-rabbit IgG conjugated to HRP (Cell Signaling Technology, Danvers, MA, USA)
were used as secondary antibody. Negative controls were prepared without using primary antibody.Cell Reports 30, 1811–1822.e1–e6, February 11, 2020 e3
Peritoneal Macrophages and BMDMs
To harvest peritoneal macrophages, 8-12 week old WT C57BL/6 mice were injected intraperitoneally with 1mL 4% thioglycolic acid.
Three days post-injection, mice were anesthetised with isoflurane and euthanized by CO2. Peritoneal cells were harvested by
washing the peritoneal cavity with ice-cold RPMI-1630 supplemented with 10% heat-inactivated FCS (BioWest) and 1% P/S. Cells
were plated after lysis of erythrocytes and non-adherent cells were washed away three hours post plating. To isolate BMDMs,
8-12 week old HilpdaDMF mice and their Hilpdaflox/flox littermates were euthanized by cervical dislocation. Both femurs and hind
legs were isolated at the hip joint, keeping femur and tibia intact. Bone marrow was extracted from the femur and tibia and differen-
tiated in DMEM, supplemented with 10% FCS, 1% P/S and 15% L929 conditioned medium. After seven days of differentiation,
BMDMs were scraped and plated as appropriate.
Cell Culture Experiments
RAW 264.7 macrophage cells (Cat#91062702; RRID: CVCL_0493, Sigma-Aldrich) were cultured in DMEM supplemented with 10%
FCS and 1% P/S. Overexpression of Hilpda was achieved by transfection with an adenoviral construct containing either Hilpda
(Ad-m-2310016C08RIK, ADV-250639, Vector Biolabs, Malvern, USA) or GFP (Ad-GFP, Cat#1060, Vector Biolabs, Malvern, USA)
in a dose of 500 MOI for 48 hours. Palmitate (Cat#P0500; CAS: 57-10-3, Sigma-Aldrich) and oleate (Cat#O1008; CAS: 112-80-1,
Sigma-Aldrich) were solubilized using EtOH and KOH and conjugated to FFA-free BSA in sterile water (Versol, Aguettant, Lyon,
France) at 37C for 30 min. Palmitate was used in concentrations of 200, 250 or 500mM. Oleate was used in a concentration of
250mM or 400mM together with 20 mM BODIPY-FL C12 (Cat#D3822, ThermoFisher Scientific, MA, USA) for fatty acid trafficking
experiments. A mixture of oleate and palmitate (oleate:palmitate) was made in a ratio of 1:2 and used in a final concentration of
600 mM. Intralipid (Fresenius Kabi AB, Uppsala, Sweden) was used in a concentration of 1 or 2mM. The addition of 100mM iron
chelator 2,20-bipyridyl (Cat#D216305; CAS: 366-18-7, Sigma-Aldrich) was used to chemically mimic hypoxia. Atglistatin
(Cat#SML1075, Sigma-Aldrich) was used in a concentration of 20mM in 100% DMSO and cells were pre-treated for 2 hours before
fatty acid loading. 24 hour treatments containing Atglistatin were refreshed every 12 hours. All cells were washed with PBS (Corning)
after treatment. BMDMs were stained with Oil Red O following standard procedures.
Confocal Imaging
To visualize fatty acid uptake, accumulation and trafficking, BMDMs were plated on 8-well m glass bottom slides (Ibidi, Martinsried,
Germany). Confocal imaging was performed on a Leica confocal TCS SP8 X system equipped with a 633 1.20 NA water-immersion
objective lens. Images were acquired using 1,024 3 1,024 pixels with pinhole set at 1 Airy Unit (AU). Excitation of the fluorescent
probes used in this study was performed using white light laser (WLL, 50% laser output) selecting the 488 nm laser line. Fluorescence
emission was detected using internal Hybrid (HyD) detector selecting a spectral window from either 520 - 580 nm (fatty acid uptake)
or from 510 – 565 nm (fatty acid trafficking).
Fatty acid uptake wasmeasured on paraformaldehyde fixed cells after 35minutes incubation with theQBT Fatty acid uptake assay
kit (Cat#R6132, Molecular Devices, California, USA) according tomanufacturer’s instructions. Image analysis was performedwith Fiji
(https://fiji.sc/) (Schindelin et al., 2012; Rueden et al., 2017). Pixels were selected for analysis using Otsu threshold, mean intensity
was quantified. The WLL laser line (488 nm) was set at a laser power of 0.2%. The pinhole was adjusted at 5.7 AU for fluorescence
intensity measurements, whereas confocal imaging was done with a pinhole of 1 AU.
Fatty acid trafficking was assessed after lipid loading for 5h and 24hwith 400 mMoleate and 20 mMBODIPY FLC12, treated either
with vehicle or Atglistatin. The WLL laser line (488 nm) was set at a laser power of 1.6% for 5 h incubated cells and 0.3% for 24 h
incubated cells. Cells were washed with PBS, fixed for 15 min with 3.7% formaldehyde and mounted with Vectashield-H (Vector
Laboratories, Peterborough, UK). Fire LUT was applied using Fiji.
To assess fatty acid accumulation, BMDMs treated with oleate:palmitate were washed with PBS and fixed for 15 minutes with
3.7% paraformaldehyde. Fixed cells were stained with 2mg/mL BODIPY 493/503 (Thermo Fisher Scientific) and mounted with
Vectashield-H (Vector Laboratories). Images were processed and analyzed with Fiji. Briefly, images were converted to binary,
watershed and LD size and number was measured with particle analysis set 0.07 mm2-infinity.
Extracellular Flux Assay
Extracellular flux of lipid-loaded BMDMs was measured using the Agilent Seahorse XF96 Analyzer (Agilent Technologies, Santa
Clara, CA, USA). Cells were seeded in a density of 200 000 cells per well in XF-96 plates (Agilent Technologies), treated appropriately
and kept in a 37C/5% CO2 incubator. An hour before the measurement, cells were washed and cultured in Seahorse XF base
medium (Agilent Technologies) without sodium bicarbonate, supplemented with 25mM glucose and 2mM L-glutamine for one
hour at 37C in a non-CO2 incubator. For the mitochondrial stress test, the following compounds were added during four injections:
oligomycin (1.5mM), FCCP (1.5 mM), pyruvate (1mM), antimycin A (2.5 mM) and rotenone (1.25 mM). The oxygen consumption rate
(OCR) was automatically measured by the sensor cartridge at baseline and following injections. Calculations were made using the
Seahorse XF-96 software Wave Desktop 2.6 (RRID: SCR_014526, Agilent Technologies).e4 Cell Reports 30, 1811–1822.e1–e6, February 11, 2020
Real-Time PCR
For cells, total RNA was isolated using TRIzol Reagent (Invitrogen, ThermoFisher Scientific). For tissues, total RNA was isolated
using the RNeasy Micro Kit (QIAGEN, Venlo, the Netherlands). cDNA was synthesized from 500ng RNA using the iScript cDNA kit
(Bio-Rad Laboratories, Hercules, CA, USA) according to manufacturer’s instructions. Real-time polymerase chain reaction
(RT-PCR) was performed with the CFX96 or CFX384 Touch Real-Time detection system (Bio-Rad Laboratories), using a SensiMix
(BioLine, London, UK) protocol for SYBR green reactions. Mouse 36b4 expression was used for normalization.
Immunoblotting
Cell or tissue protein lysates were separated by electrophoresis on pre-cast 4%–15% polyacrylamide gels and transferred onto
nitrocellulose membranes using a Trans-Blot Semi-Dry transfer cell (all purchased from Bio-Rad Laboratories), blocked in
non-fat milk and incubated overnight at 4C with primary antibody for HILPDA (Cat#sc-137518; RRID: AB_2011522, Santa Cruz
Biotechnology), ATGL (Cat#sc-365278, RRID:AB_10859044, Santa Cruz Biotechnology), PLIN3 (Cat#10694-1-AP, RRI-
D:AB_2297252, Proteintech), G0S2 (Cat#sc-518067, Santa Cruz Biotechnology), ACTIN (Cat#5057; RRID: AB_10694076, Cell
Signaling Technology), TUBULIN (Cat#2146; RRID: AB_2210545, Cell Signaling Technology) or HSP90 (Cat#4874S; RRID:
AB_2121214, Cell Signaling Technology). Membranes were incubated with secondary antibody (Anti-rabbit IgG, HRP-linked
Antibody, 7074, Cell Signaling Technology) and developed using Clarity ECL substrate (Bio-Rad Laboratories). Images were
captured with the ChemiDoc MP system (Bio-Rad Laboratories).
Enzyme-Linked Immunosorbent Assay (ELISA)
DuoSet sandwich ELISA kits for TNFa, IL10 and IL6 (Cat#DY410/Cat#DY417/Cat#DY406, R&D systems) were used to measure
cytokine concentrations in cell or explant supernatant according tomanufacturer’s instructions. Data were normalized for the amount
of adipose tissuemacrophages by determining the concentration of DNA per well (Quant-iT dsDNAAssay Kit high sensitivity, Thermo
Fisher Scientific) and normalized for gWAT explants to the weight per explant.
Lipidomics
Lipidomics analysis was performed as described (Herzog et al., 2016). The HPLC system consisted of an Ultimate 3000 binary HPLC
pump, a vacuum degasser, a column temperature controller, and an auto sampler (Thermo Fisher Scientific). The column tempera-
ture was maintained at 25C. The lipid extract was injected onto a ‘‘normal phase column’’ LiChrospher 2x250-mm silica-60 column,
5 mm particle diameter (Merck) and a ‘‘reverse phase column’’ Acquity UPLC HSS T3, 1.8 mm particle diameter (Waters, Milford, MA,
USA). A Q Exactive Plus Orbitrap (Thermo Fisher Scientific) mass spectrometer was used in the negative and positive electrospray
ionization mode. Nitrogen was used as the nebulizing gas. The spray voltage used was 2500 V, and the capillary temperature was
256C. S-lens RF level: 50, auxiliary gas: 11, auxiliary temperature 300C, sheath gas: 48, sweep cone gas: 2. In both the negative and
positive ionization mode, mass spectra of the lipid species were obtained by continuous scanning from m/z 150 to m/z 2000 with a
resolution of 280,000 full width at half maximum (FWHM). Data were analyzed and visualized using R programming language (CRAN,
RRID: SCR_003005, https://www.r-project.org).
Microarray Analyses
Microarray analysis was performed on a several experiments: 1) Peritoneal macrophages treated with various fatty acids (500 mM)
for 6 hours. 2) Peritoneal macrophages treated with intralipid (2mM) for 6 hours. 3) BMDM samples from HilpdaDMF mice and
Hilpdaflox/flox mice lipid loaded with oleate:palmitate (600mM) for 12 and 24 hours. RNA was isolated as described above and purified
with the RNeasy Micro kit from QIAGEN. Integrity of the RNA was verified with RNA 6000 Nano chips using an Agilent 2100
bioanalyzer (Agilent Technologies). Purified RNA (100 ng per sample) was labeled with the Whole-Transcript Sense Target Assay
kit (Affymetrix, Santa Clara, CA, USA; P/N 900652) and hybridized to an Affymetrix Mouse Gene 1.0 arrays or 2.1 ST array plate
(Affymetrix). Hybridization, washing, and scanning were carried out on an Affymetrix GeneTitan platform according to the
manufacturer’s instructions.
Visualization
The 3D scatterplot of signal log ratio’s (Figure 1A) was created using R programming language (https://www.r-project.org) and the R
package ‘‘plot3D.’’ Heat-maps for the lipidomics were created using the package ‘‘gplots’’ and. The graphical abstract was created
with BioRender.
QUANTIFICATION AND STATISTICAL ANALYSIS
Power Calculation
From earlier studies it is known that fasting glucose values of mice fed a high fat diet differs on average 3mM (+ 8 mM – 11mM)
compared to mice fed a low fat diet. Differences in responses lead to a standard deviation around 2mM or higher. For the powerCell Reports 30, 1811–1822.e1–e6, February 11, 2020 e5
calculation, we used a one-way ANOVAwith a significance level of 0.05 and a power of 90%, leading to an estimation of around n = 11
mice needed per group. To allow compensation for unforeseen circumstances or potential loss of mice during the study, n = 12 mice
were included per group.
Statistical Analysis
Normalization of the arrays was performed with the Robust Multi-array Average method (Bolstad et al., 2003; Irizarry et al., 2003).
Probe sets were redefined according to Dai et al. (2005) based on annotations provided by the Entrez Gene database. Data for
the 3D scatterplot of signal log ratio’s (Figure 1A) was created using R programming language (https://www.r-project.org). Partial
least-squares regression analysis for the lipidomics data was performed using the R package ‘‘mixOMICS.’’
Details on statistical analyses are given in figure legends. In experiments where animals were included, n represents the number of
animals used. For cell experiments, n represents the number of replications performed. Data are represented asmeans ± SD or SEM
as indicated. Assumptions for statistical methods were tested and statistical analyses were carried out using an unpaired Student’s t
test or two-way ANOVA followed by Bonferroni’s post hocmultiple comparisons test, if genotype and diet or genotype and treatment
both were found significant (GraphPad Software, San Diego, CA, USA). A value of p < 0.05 was considered statistically significant.
DATA AND CODE AVAILABILITY
A publicly available dataset (GEO: GSE77104) was downloaded fromGene Expression Omnibus and further processed as described
above to obtain individual gene expression data (Robblee et al., 2016). The microarray analysis of the adipose tissue macrophages
(GEO: GSE84000) and peritoneal macrophages treated with intralipid (GEO: GSE136240) are already described elsewhere (Boutens
and Stienstra, 2016; Oteng et al., 2019). The accession number for the microarray datasets reported in this paper is GEO:
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